3 ·Filed Sep 16, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Routine initial ownership filing with no securities reported. Monitor future Form 4 filings for any open-market purchases or grants that would indicate insider conviction.
Latest settled — T+20d
INMB ▼ -24.31% at T+20d
NEUTRAL call -24.31% · α vs SPY -25.52% · entry $2.18 → $1.65
Latest observation: T+26 -40.70% FF3 residual α
T+1d
+6.88%
call +6.88% · α +7.00%
$2.33
settled 6w ago
T+5d
-8.26%
call -8.26% · α -8.86%
$2.00
settled 5w ago
T+20d
-24.31%
call -24.31% · α -25.52%
$1.65
settled 13d ago
T+60d
Pending
in 6w
Price Chart
Loading chart...
Executive Summary
James Sapirstein filed a Form 3 initial statement of beneficial ownership with the SEC, reporting no securities beneficially owned in Inmune Bio, Inc. as of September 8, 2026. This is a routine insider filing with no trading activity or material financial information.
Key Facts
- James Sapirstein filed a Form 3 initial statement of beneficial ownership on September 16, 2026, for the period ending September 8, 2026.
- The filing reports zero shares, options, or other derivative securities beneficially owned.
- The filing is a standard SEC requirement for new reporting persons (officers, directors, or 10% holders).
Financial Impact
No financial impact — zero securities reported.
Risk Factors
- No material risks identified from this filing alone.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-100650 |
| Document: 0001213900-26-100650-index.html | 0001213900-26-100650 |
| Document: 0001213900-26-100650.txt | 0001213900-26-100650 |
12 reports for INMB
100% Hit rate @ T+60 Went positive at some point 4 of 6 best @ T+60▲ +81.82%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $1.61 | awaiting T+60 | — | $1.43 (−11.18%) |
Sep 16, 2026 5w ago | 3 | $2.18 | awaiting T+60 | — | $1.43 (−34.40%) |
Jul 9, 2026 15w ago | Press Release | $1.79 $1.93 | ▲ +7.82% | ▲ +6.19% | $1.43 (−20.11%) |
Jul 1, 2026 16w ago | 8-K | $1.68 | awaiting T+60 | — | $1.43 (+14.88%) |
Jun 23, 2026 17w ago | 8-K | $1.35 | awaiting T+60 | — | $1.43 (+5.93%) |
Jun 17, 2026 18w ago | 8-K | $1.45 | awaiting T+60 | — | $1.43 (−1.38%) |
Jun 2, 2026 20w ago | 8-K | $1.32 $2.40 | ▲ +81.82% | ▲ +79.32% | $1.43 (+8.33%) |
May 7, 2026 24w ago | Press Release | $1.43 $1.91 | ▲ +33.57% | ▲ +28.73% | $1.43 (−0.00%) |
May 5, 2026 24w ago | 8-K | $1.52 $1.75 | ▲ +15.13% | ▲ +13.07% | $1.43 (−5.92%) |
Apr 30, 2026 25w ago | Press Release | $1.43 | awaiting T+60 | — | $1.43 (−0.00%) |
Showing 10 of 12
US Market Status
Market Closed — Opens in 2h 32m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers